Bevacizumab increases the risk of infections in cancer patients: A systematic review and pooled analysis of 41 randomized controlled trials

MLA

Qing Zhang, et al. “Bevacizumab Increases the Risk of Infections in Cancer Patients: A Systematic Review and Pooled Analysis of 41 Randomized Controlled Trials.” Critical Reviews in Oncology/Hematology, vol. 94, June 2015, pp. 323–36. EBSCOhost, https://doi.org/10.1016/j.critrevonc.2015.02.007.

APA

Qing Zhang, Shen Fu, Wei-Xiang Qi, & Xiao-Mao Guo. (2015). Bevacizumab increases the risk of infections in cancer patients: A systematic review and pooled analysis of 41 randomized controlled trials. Critical Reviews in Oncology/Hematology, 94, 323–336. https://doi.org/10.1016/j.critrevonc.2015.02.007

Chicago

Qing Zhang, Shen Fu, Wei-Xiang Qi, and Xiao-Mao Guo. 2015. “Bevacizumab Increases the Risk of Infections in Cancer Patients: A Systematic Review and Pooled Analysis of 41 Randomized Controlled Trials.” Critical Reviews in Oncology/Hematology 94 (June): 323–36. doi:10.1016/j.critrevonc.2015.02.007.